Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-000130
Filing Date
2025-01-03
Accepted
2025-01-03 16:30:18
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-67714.html 4  
1 PRIMARY DOCUMENT marketforms-67714.xml 4 5597
  Complete submission text file 0001214659-25-000130.txt   7313
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XOMA CORPORATION 2200 POWELL STREET, SUITE 310 EMERYVILLE CA 94608
Business Address
Sitko Bradley (Reporting) CIK: 0001959809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39801 | Film No.: 25506821